Welcome to AFM-Telethon's website
We are pleased to announce that our 9th international congress dedicated to muscle biology and neuromuscular diseases, MYOLOGY 2027, will take place in STRASBOURG, France, on May 10-13, 2027. Don't miss the chance to be part of this major global gathering of myology experts!
Expert care pathways, new therapeutic approaches and clinical trial results… Here is an overview of recent studies shedding light on the management of myasthenia gravis and opening new perspectives for GNE myopathy and myositis.
On 17 and 18 June 2026, the GenoTher biocluster will bring together leading international experts in genetic medicine at the Maison de l’Océan in Paris for the GenoTher Summit 2026.
At ASGCT 2026 in Boston, Genethon presented new clinical data from three of its gene therapy programs in Duchenne muscular dystrophy, gamma-sarcoglycanopathy (LGMD-R5), and Crigler-Najjar syndrome. In total, Genethon teams presented 8 oral presentations and 13 posters.
The French Muscular Dystrophy Association (AFM-Téléthon) is a patient-led organisation driving research and support for people with rare genetic diseases. From groundbreaking therapies to daily care, discover how AFM-Téléthon turns innovation into hope.
You live abroad and want to be part of the great Telethon adventure? Join us!
